WATERTOWN, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals, the leader in the discovery and development of novel gene control therapies, announced today that Chief Financial Officer Jorge Conde will present a corporate overview at the 2015 JMP Securities Life Sciences Conference. The presentation will take place at 1:00 p.m. ET on Wednesday, June 24, 2015, at the St. Regis New York hotel in New York City.
About Syros Pharmaceuticals
Syros Pharmaceuticals is a therapeutics company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases. Syros’ proprietary platform identifies the master switches for disease genes, opening a whole new approach to novel therapeutics and biomarkers. The Company’s founders are pioneers in gene control research and translation. Co-founded by Flagship Ventures and ARCH Venture Partners, Syros Pharmaceuticals is located in Watertown, Mass. For more information, visit www.syros.com.
Ten Bridge Communications, Inc.
Dan Quinn, 781-475-7974
Source: Syros Pharmaceuticals
Released June 18, 2015